| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |